Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-24-000089
Filing Date
2024-11-14
Accepted
2024-11-14 16:11:03
Documents
46
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20240930.htm   iXBRL 10-Q 534509
2 EX-31.1 slrx20240930ex-311.htm EX-31.1 8879
3 EX-31.2 slrx20240930ex-312.htm EX-31.2 8669
4 EX-32.1 slrx20240930ex-321.htm EX-32.1 6215
  Complete submission text file 0001615219-24-000089.txt   2853408

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20240930.xsd EX-101.SCH 21012
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20240930_cal.xml EX-101.CAL 23707
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20240930_def.xml EX-101.DEF 74671
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20240930_lab.xml EX-101.LAB 277155
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20240930_pre.xml EX-101.PRE 183041
49 EXTRACTED XBRL INSTANCE DOCUMENT flks-20240930_htm.xml XML 246719
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 241462242
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)